IMMUNODIAGNOSTIC SYSTEMS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
IMMUNODIAGNOSTIC SYSTEMS
Largest movements
- Receivables within one year +€1.2m
up €1.2m (+34.7%), from €3.5m to €4.7m
of which Other amounts receivable: +€1.2m
- Stocks and contracts -€357,587
down €357,587 (-7.2%), from €5.0m to €4.6m
- Cash +€108,785
up €108,785 (+29.7%), from €365,810 to €474,595
mainly Net result for the year (+€577,381) and Trade debts (+€452,389)
- Profit (loss) carried forward +€577,381
up €577,381 (+33.3%), from €1.7m to €2.3m
- Trade debts +€452,389
up €452,389 (+23.9%), from €1.9m to €2.3m
- Turnover +€1.2m
up €1.2m (+10.6%), from €11.6m to €12.8m
- Write-downs +€788,021
up €788,021, from -€753,207 to €34,814
- Goods and materials +€663,157
up €663,157 (+13.7%), from €4.8m to €5.5m
of which Purchases: +€665,112
- Other operating income -€152,823
down €152,823 (-16.5%), from €927,913 to €775,091
- Staff costs +€146,977
up €146,977 (+3.1%), from €4.7m to €4.8m
From the 31-12-2024 result to the 31-12-2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 31-12-2024 and 31-12-2025 balance sheets and the 31-12-2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 31-12-2024 | 31-12-2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €9,660,768 | €10,692,252 | +€1.0m | +10.7% |
| Fixed assets | 21/28 | €792,024 | €855,886 | +€63,862 | +8.1% |
| Intangible fixed assets | 21 | €22,351 | €14,901 | -€7,451 | -33.3% |
| Tangible fixed assets | 22/27 | €769,673 | €840,985 | +€71,312 | +9.3% |
| Land and buildings | 22 | €269,381 | €251,967 | -€17,414 | -6.5% |
| Plant, machinery and equipment | 23 | €180,410 | €247,957 | +€67,547 | +37.4% |
| Furniture and vehicles | 24 | €126,256 | €193,312 | +€67,056 | +53.1% |
| Assets under construction and advance payments | 27 | €193,625 | €147,748 | -€45,877 | -23.7% |
| Financial fixed assets | 28 | €0 | €0 | = | |
| Affiliated companies | 280/1 | €0 | €0 | = | |
| Amounts receivable | 281 | €0 | €0 | = | |
| Other financial fixed assets | 284/8 | €0 | €0 | = | |
| Amounts receivable and cash guarantees | 285/8 | €0 | €0 | = | |
| Current assets | 29/58 | €8,868,743 | €9,836,366 | +€967,623 | +10.9% |
| Stocks and contracts in progress | 3 | €4,970,941 | €4,613,354 | -€357,587 | -7.2% |
| Stocks | 30/36 | €4,970,941 | €4,613,354 | -€357,587 | -7.2% |
| Raw materials and consumables | 30/31 | €1,723,402 | €1,133,407 | -€589,996 | -34.2% |
| Work in progress | 32 | €1,843,473 | €2,371,349 | +€527,876 | +28.6% |
| Finished goods | 33 | €1,404,066 | €1,108,598 | -€295,468 | -21.0% |
| Amounts receivable within one year | 40/41 | €3,505,760 | €4,721,352 | +€1.2m | +34.7% |
| Trade receivables | 40 | €69,687 | €57,096 | -€12,591 | -18.1% |
| Other amounts receivable | 41 | €3,436,074 | €4,664,257 | +€1.2m | +35.7% |
| Cash at bank and in hand | 54/58 | €365,810 | €474,595 | +€108,785 | +29.7% |
| Deferred charges and accrued income | 490/1 | €26,232 | €27,065 | +€834 | +3.2% |
| Total equity and liabilities | 10/49 | €9,660,768 | €10,692,252 | +€1.0m | +10.7% |
| Equity | 10/15 | €6,802,111 | €7,378,376 | +€576,265 | +8.5% |
| Contributions | 10/11 | €4,497,677 | €4,497,677 | = | 0.0% |
| Capital | 10 | €4,497,677 | €4,497,677 | = | 0.0% |
| Issued capital | 100 | €4,497,677 | €4,497,677 | = | 0.0% |
| Reserves | 13 | €560,973 | €560,973 | = | 0.0% |
| Non-distributable reserves | 130/1 | €523,888 | €523,888 | = | 0.0% |
| Legal reserve | 130 | €523,888 | €523,888 | = | 0.0% |
| Distributable reserves | 133 | €37,084 | €37,084 | = | 0.0% |
| Profit (loss) carried forward | 14 | €1,734,227 | €2,311,608 | +€577,381 | +33.3% |
| Investment grants | 15 | €9,234 | €8,118 | -€1,116 | -12.1% |
| Amounts payable | 17/49 | €2,858,657 | €3,313,877 | +€455,220 | +15.9% |
| Amounts payable within one year | 42/48 | €2,858,657 | €3,313,877 | +€455,220 | +15.9% |
| Trade debts | 44 | €1,895,774 | €2,348,163 | +€452,389 | +23.9% |
| Suppliers | 440/4 | €1,895,774 | €2,348,163 | +€452,389 | +23.9% |
| Taxes, remuneration and social security | 45 | €962,877 | €965,709 | +€2,831 | +0.3% |
| Taxes | 450/3 | €59,184 | €390,116 | +€330,932 | +559% |
| Remuneration and social security | 454/9 | €903,693 | €575,593 | -€328,101 | -36.3% |
| Other amounts payable | 47/48 | €5 | €5 | = | 0.0% |
| Accrued charges and deferred income | 492/3 | €0 | - | = | |
| Operating income | 70/76A | €11,424,899 | €13,206,943 | +€1.8m | +15.6% |
| Turnover | 70 | €11,603,324 | €12,832,055 | +€1.2m | +10.6% |
| Change in stocks of work in progress, finished goods and contracts in progress | 71 | -€1,106,339 | -€400,203 | +€706,136 | +63.8% |
| Other operating income | 74 | €927,913 | €775,091 | -€152,823 | -16.5% |
| Operating charges | 60/66A | €10,868,932 | €12,477,588 | +€1.6m | +14.8% |
| Goods for resale, raw materials and consumables | 60 | €4,846,767 | €5,509,924 | +€663,157 | +13.7% |
| Purchases | 600/8 | €4,284,873 | €4,949,985 | +€665,112 | +15.5% |
| Change in stocks: decrease (increase) | 609 | €561,895 | €559,939 | -€1,955 | -0.3% |
| Services and other goods | 61 | €1,802,674 | €1,893,650 | +€90,976 | +5.0% |
| Remuneration, social security and pensions | 62 | €4,676,653 | €4,823,630 | +€146,977 | +3.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €239,141 | €156,401 | -€82,740 | -34.6% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | -€753,207 | €34,814 | +€788,021 | |
| Other operating charges | 640/8 | €56,904 | €59,169 | +€2,266 | +4.0% |
| Operating profit (loss) | 9901 | €555,967 | €729,355 | +€173,388 | +31.2% |
| Financial income | 75/76B | €128,605 | €148,012 | +€19,406 | +15.1% |
| Recurring financial income | 75 | €128,605 | €148,012 | +€19,406 | +15.1% |
| Income from financial fixed assets | 750 | €62,606 | €119,898 | +€57,293 | +91.5% |
| Other financial income | 752/9 | €66,000 | €28,113 | -€37,886 | -57.4% |
| Financial charges | 65/66B | €29,838 | €27,242 | -€2,595 | -8.7% |
| Recurring financial charges | 65 | €29,838 | €27,242 | -€2,595 | -8.7% |
| Debt charges | 650 | €2,744 | €2,868 | +€123 | +4.5% |
| Other financial charges | 652/9 | €27,093 | €24,375 | -€2,719 | -10.0% |
| Profit (loss) for the period before taxes | 9903 | €654,735 | €850,124 | +€195,389 | +29.8% |
| Income taxes | 67/77 | €210,733 | €272,743 | +€62,011 | +29.4% |
| Taxes | 670/3 | €210,733 | €272,743 | +€62,011 | +29.4% |
| Profit (loss) for the period | 9904 | €444,002 | €577,381 | +€133,379 | +30.0% |
| Profit (loss) for the period to be appropriated | 9905 | €444,002 | €577,381 | +€133,379 | +30.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 October 2026 via checked.be.